Xylo Technologies Ltd (XYLO)

Market Cap	6.49M
Revenue (ttm)	29.86M -67.4%
Net Income	-6.03M
EPS	-8.10
Shares Out	1.28M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,148
Open	5.07
Previous Close	5.07
Day's Range	5.07 - 5.12
52-Week Range	2.71 - 5.85
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 19, 2025

About XYLO

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. It also provides digital advertising platform; and operates online stor...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 38
• Stock Exchange: NASDAQ
• Ticker Symbol: XYLO
• Website: https://www.medigus.com

Financial Performance

In 2024, Xylo Technologies's revenue was $29.86 million, a decrease of -67.45% compared to the previous year's $91.72 million. Losses were -$6.03 million, -62.39% less than in 2023.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Jan 1, 2000

Data Sources Report a data error